RIVERHEAD CAPITAL MANAGEMENT LLC - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 246 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 0.69 and the average weighting 0.1%.

Quarter-by-quarter ownership
RIVERHEAD CAPITAL MANAGEMENT LLC ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2019$162,000
-13.8%
5,886
+3.5%
0.01%
-14.3%
Q2 2019$188,000
-5.5%
5,6860.0%0.01%
-12.5%
Q1 2019$199,000
+5.3%
5,6860.0%0.01%0.0%
Q4 2018$189,000
-33.9%
5,6860.0%0.01%
-20.0%
Q3 2018$286,000
+1.8%
5,686
+21.3%
0.01%
-9.1%
Q2 2018$281,000
+30.7%
4,6860.0%0.01%
+22.2%
Q1 2018$215,000
+20.1%
4,686
+4.5%
0.01%
+12.5%
Q4 2017$179,000
+25.2%
4,486
+25.1%
0.01%
+14.3%
Q3 2017$143,000
+8.3%
3,586
+17.1%
0.01%0.0%
Q2 2017$132,000
+164.0%
3,062
+91.4%
0.01%
+133.3%
Q1 2017$50,000
+42.9%
1,600
+14.3%
0.00%
+50.0%
Q4 2016$35,0000.0%1,4000.0%0.00%0.0%
Q3 2016$35,000
-39.7%
1,400
-35.7%
0.00%
+100.0%
Q2 2016$58,000
-58.6%
2,178
-76.2%
0.00%
-50.0%
Q1 2016$140,000
+9.4%
9,144
-3.7%
0.00%0.0%
Q4 2015$128,0009,5000.00%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q3 2019
NameSharesValueWeighting ↓
NEA Management Company, LLC 7,641,250$107,207,0007.06%
HealthInvest Partners AB 782,746$10,982,0006.50%
KOPP INVESTMENT ADVISORS LLC 729,960$10,241,0005.51%
Murphy Michael R 1,028,304$14,427,0004.96%
Opaleye Management Inc. 460,000$6,454,0003.18%
ASHFORD CAPITAL MANAGEMENT INC 511,244$7,173,0001.68%
Bruce & Co., Inc. 394,581$5,535,0001.42%
AlphaOne Investment Services, LLC 235,065$3,297,0001.40%
Ranger Investment Management 1,560,453$21,893,0001.23%
NORTHPOINTE CAPITAL LLC 584,753$8,204,0001.07%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders